Create
Log in
Enquire now
Translation-X
Developer of novel therapeutics for autism spectrum disorders.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Organization
Company
CEO
Özgür Genç
Email Address
ozgur.genc@unibas.ch
Founded Date
2022
Founder
Özgür Genç
Industry
Biotechnology
Health technology
Investors
Venture Kick
Latest Funding Round Date
October 2, 2024
Latest Funding Round Amount (USD)
177,000
Latest Funding Type
Pre-Seed
LinkedIn URL
@company/translation-x
Location
Basel
Switzerland
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
177,000
Official Website
trx-therapeutics.com
Find more companies like Translation-X
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Pricing
Enterprise
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE